
LB Pharmaceuticals Inc Common Stock
LBRXHealthcare|Biotechnology|US
$42.01
+3.92 (+10.29%)
DCF Value
$9.67
Tangible Book / Share
$12.63
Cash / Share
$12.21
Next Earnings Report
Mar 25, 2027
EPS est. -$1.64
Financing Filings (last 12 months)
11
Shelf registrations / offering prospectuses — latest Oct 1, 2026 (S-3ASR). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
LB Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 5, 2026 · GlobeNewsWire
LB Pharmaceuticals to Participate in Upcoming Investor Events
Oct 15, 2026 · GlobeNewsWire
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
Oct 6, 2026 · GlobeNewsWire
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D.
Sep 15, 2026 · GlobeNewsWire
LB Pharmaceuticals to Participate in Upcoming September Investor Events
Sep 3, 2026 · GlobeNewsWire
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
Sep 3, 2026 · GlobeNewsWire
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 11, 2026 · GlobeNewsWire
SEC Filings (70)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Oct 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 5, 2026 | EFFECT | DocumentIndex | |
| Oct 1, 2026 | POS AM | DocumentIndex | |
| Oct 1, 2026 | S-3ASR | Shelf registration | DocumentIndex |
| Sep 15, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 15, 2026 | 8-K | Material event | DocumentIndex |
| Sep 3, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 3, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 11, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2026 | 8-K | Material event | DocumentIndex |
| Jul 29, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 29, 2026 | 8-K | Material event | DocumentIndex |
| Jul 22, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 22, 2026 | 8-K | Material event | DocumentIndex |
| Jul 16, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 10, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jun 10, 2026 | 8-K | Material event | DocumentIndex |
| Jun 9, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jun 9, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| Apr 23, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 23, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 23, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 14, 2026 | EFFECT | DocumentIndex | |
| Apr 14, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 6, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Mar 26, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 26, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |